Sino Biopharmaceutical Limited: all 470 studies

Page 3 of 5. Open to participants first (164), then studies with results posted, then the rest; newest registration first within each.

• A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting ConditionsActive, not recruitingNCT06487416Phase 1
• A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal PolypsCompletedNCT06451640Phase 2
• A Clinical Trial of TQC2938 Injection in Healthy Adult SubjectsActive, not recruitingNCT06449859Phase 1
• Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal PolypsCompletedNCT06439381Phase 2
• TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid TumorsTerminatedNCT06438783Phase 1
• A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)Active, not recruitingNCT06433531Phase 1
• Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 TabletsCompletedNCT06431438Phase 1
• A Study of TQC3927 Powder for Inhalation in Healthy Adult SubjectsCompletedNCT06408285Phase 1
• TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant PatientsTerminatedNCT06388759Phase 1
• LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.Active, not recruitingNCT06351020Phase 3
• A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant CancerCompletedNCT06344351Phase 1
• A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)Active, not recruitingNCT06326671Phase 1
• Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.TerminatedNCT06320080Phase 1
• A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia AActive, not recruitingNCT06297655Phase 3
• TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.TerminatedNCT06297642Phase 1
• A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic CancerCompletedNCT06278493Phase 1/2
• A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)TerminatedNCT06245941Phase 1/2
• A Clinical Trial of TQH3906 Capsules in Healthy VolunteersCompletedNCT06230588Phase 1
• A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerActive, not recruitingNCT06198751Phase 2
• A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid TumorsCompletedNCT06172309Phase 1
• TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))Active, not recruitingNCT06169722Phase 1/2
• A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant CancerWithdrawnNCT06165809Phase 1
• A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult SubjectsCompletedNCT06160895Phase 1
• A Clinical Study of TQH2929 in Healthy Adult SubjectsCompletedNCT06156280Phase 1
• A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis BActive, not recruitingNCT06150014Phase 1/2
• A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.TerminatedNCT06143423Phase 1
• A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese SubjectsCompletedNCT06126562Phase 1
• A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid TumorsActive, not recruitingNCT06116240Phase 1
• A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast CancerCompletedNCT06115902Phase 1
• TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)TerminatedNCT06106841Phase 1/2
• A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.CompletedNCT06089278Phase 2
• A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated PainCompletedNCT06076486Phase 3
• Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic PatientsCompletedNCT06051565Phase 1/2
• A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal PolypsCompletedNCT06036927Phase 2
• A Study to Evaluate Drug-Drug Interaction of TQ05105 TabletsCompletedNCT06024915Phase 1
• Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide NanoparticleCompletedNCT06010537Early Phase 1
• A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical CancerWithdrawnNCT05998941Phase 2
• A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant TumorCompletedNCT05997342Phase 1
• A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.CompletedNCT05987371Phase 2
• A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.Active, not recruitingNCT05987358Phase 3
• Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.Status unknownNCT05985187Phase 3
• To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult SubjectsCompletedNCT05982106Phase 1
• A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).TerminatedNCT05975645Phase 1
• A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisStatus unknownNCT05970432Phase 2
• To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.Status unknownNCT05859373Phase 1/2
• A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid ArthritisTerminatedNCT05849727Phase 2
• Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaTerminatedNCT05834543Phase 1/2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid TumorsStatus unknownNCT05818917Phase 1
• Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian CancerCompletedNCT05815862Phase 2
• Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male VolunteersCompletedNCT05800418Phase 1
• A Bioequivalence Study of Sunitinib Malate Capsules.CompletedNCT05800106Phase 1
• Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancerActive, not recruitingNCT05780567Phase 3
• A Clinical Trial of TQB3909 Tablets in Patients With Breast CancerStatus unknownNCT05775575Phase 1/2
• Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male VolunteersCompletedNCT05765357Phase 1
• Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid CancerCompletedNCT05745363Phase 1/2
• Clinical Trial of the TQB2102 Injection in Patients With Advanced CancersActive, not recruitingNCT05735496Phase 1
• Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance ImagingStatus unknownNCT05687864Phase 1
• Material Balance Study of TQ-B3525Status unknownNCT05675202Phase 1
• Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell DiseasesWithdrawnNCT05647512Phase 1/2
• Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid TumorsStatus unknownNCT05645315Phase 1/2
• A Bioequivalence Study of Dasatinib TabletCompletedNCT05640804Phase 1
• A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation TestStatus unknownNCT05634473Not applicable
• Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor SubjectsStatus unknownNCT05610202Phase 1
• To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic RhinitisTerminatedNCT05607446Phase 1
• TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaCompletedNCT05563480Phase 2
• Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction PatientsStatus unknownNCT05559242Phase 1
• A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid TumorsActive, not recruitingNCT05518045Phase 1/2
• TQB3616 Capsules in the Treatment of Dedifferentiated LiposarcomaTerminatedNCT05496569Phase 2
• Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological TumorsStatus unknownNCT05489276Phase 1
• Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With InhibitorStatus unknownNCT05487976Phase 3
• Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.TerminatedNCT05481645Phase 2
• A Phase I Clinical Trial of Bevacizumab InjectionCompletedNCT05476341Phase 1
• Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.CompletedNCT05472324Phase 2
• Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced MelanomaStatus unknownNCT05451407Phase 1
• Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary CholangitisCompletedNCT05450887Phase 3
• Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic SyndromesStatus unknownNCT05426798Phase 1
• Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid TumorsStatus unknownNCT05416359Phase 1
• A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult SubjectsStatus unknownNCT05409326Phase 1
• To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate CancerTerminatedNCT05405439Phase 1/2
• To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory LymphomaStatus unknownNCT05400876Phase 1/2
• A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy SubjectsCompletedNCT05380934Phase 1
• Clinical Trial of the TQB2930 Injection in Patients With Advanced CancersStatus unknownNCT05380882Phase 1
• TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical TrailCompletedNCT05375461Phase 3
• To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerActive, not recruitingNCT05365178Phase 3
• Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male VolunteersStatus unknownNCT05353179Early Phase 1
• A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).Status unknownNCT05346952Phase 3
• Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult SubjectsCompletedNCT05344729Phase 1
• To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult SubjectsStatus unknownNCT05340530Phase 1
• Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced CancersActive, not recruitingNCT05333276Phase 1
• A Phase II Clinical Trial of TQC3721 Suspension for InhalationTerminatedNCT05292196Phase 2
• TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung CancerStatus unknownNCT05284994Phase 1/2
• Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade SarcomaTerminatedNCT05262101Phase 2
• Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid TumoursTerminatedNCT05255484Phase 1/2
• Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant TumorsStatus unknownNCT05213767Phase 1
• Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid TumoursCompletedNCT05199753Phase 1/2
• To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal CancerStatus unknownNCT05198531Phase 1/2
• Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant TumorsStatus unknownNCT05198505Phase 1
• A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic CarcinomaTerminatedNCT05193604Phase 1
• Clinical Trial of the TQB2928 Injection in Patients With Advanced CancersStatus unknownNCT05192512Phase 1
• Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid TumorsCompletedNCT05188664Phase 1/2

← Sino Biopharmaceutical Limited overview and focus areas